The Effectivity of Combination of Standard Interferon-alpha

被引:0
|
作者
Ozgunes, Nail [1 ]
Sargin, Fatma [1 ]
Yazici, Saadet [1 ]
Ceylan, Nuket [1 ]
Ucisik, Ayse Canan [1 ]
Ergen, Pinar [1 ]
Dogru, Arzu [1 ]
Aydin, Ozlem [1 ]
机构
[1] SB Goztepe Egitim & Arastirma Hastartesi, Infeks Elastaliklan & Klin Mikrobiyol Klin, Istanbul, Turkey
来源
VIRAL HEPATIT DERGISI-VIRAL HEPATITIS JOURNAL | 2006年 / 11卷 / 02期
关键词
Chronic hepatitis C; interferon alpha; pegylated interferon alpha; ribavirin;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
This study was done in order to evaluate the effectivity of combination therapy of standard interferon alpha (IFN-alpha) + ribavirin and pegylated IFN-alpha (PEG-IFN-alpha) + ribavirin in patients with chronic hepatitis C between 2003-2005 years in our clinic. Totally 52 patients were included in the study. In the combination treatment protocols, standard IFN-alpha 2 alpha or 2b plus ribavirin was given in 35 patients (group I) and PEG-IFN-a plus ribavirin in 17 patients (group II). Duration of treatment was 12 months. Rate of biochemical and virological responses at the end of the therapy and sustained response were 66.6%, 78.7%, 57.7% in group I and 71.4%, 85%, 66.7% in group II, respectively In conclusion, treatment protocols was effective in both groups and the rate of biochemical and virologic responses at the end of the therapy and sustained response were higher in group II than group I but the differences between groups were not significant. In according to the results of this study; PEG-IFN should be preferred to standard IFN-alpha.
引用
收藏
页码:61 / 64
页数:4
相关论文
共 50 条
  • [41] COMBINATION CHEMOTHERAPY OF FOTEMUSTINE-DACARBAZINE AND INTERFERON-ALPHA FOR DISSEMINATED MALIGNANT-MELANOMA TREATMENT
    CELERIER, P
    DRENO, B
    BUREAU, B
    LITOUX, P
    ANNALES DE DERMATOLOGIE ET DE VENEREOLOGIE, 1993, 120 (6-7): : 437 - 440
  • [42] TREATMENT OF METASTATIC RENAL-CELL CARCINOMA WITH A COMBINATION OF HUMAN LYMPHOBLASTOID INTERFERON-ALPHA AND CIMETIDINE
    KOTAKE, T
    KINOUCHI, T
    SAIKI, S
    KURODA, M
    MIKI, T
    KIYOHARA, H
    USAMI, M
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 1991, 21 (01) : 46 - 51
  • [43] INTERMITTENT INTERFERON-alpha USE IN RENAL METASTASES
    Gutorov, S. L.
    Chernoglazova, Ye. V.
    Vetrova, N. A.
    ONKOUROLOGIYA, 2009, 5 (02): : 31 - 35
  • [44] Combination of chemotherapy and recombinant interferon-alpha in advanced non-small cell lung cancer
    Hasturk, S
    Kurt, B
    Kocabas, A
    Nadirler, F
    Oruc, O
    CANCER LETTERS, 1997, 112 (01) : 17 - 22
  • [45] The combination of MLN2238 (Ixazomib) with interferon-alpha results in enhanced cell death in melanoma
    Suarez-Kelly, Lorena P.
    Kemper, Gregory M.
    Duggan, Megan C.
    Stiff, Andrew
    Nole, Tiffany C.
    Markowitz, Joseph
    Luedke, Eric A.
    Yildiz, Vedat O.
    Yu, Lianbo
    Jaime-Ramirez, Alena Cristina
    Karpa, Volodymyr
    Zhang, Xiaoli
    Carson, William E., III
    ONCOTARGET, 2016, 7 (49) : 81172 - 81186
  • [46] TREATMENT OF GASTROINTESTINAL AND RENAL ADENOCARCINOMAS WITH INTERFERON-ALPHA
    MEADOWS, LM
    LINDLEY, C
    OZER, H
    BIOTHERAPY, 1992, 4 (03) : 179 - 187
  • [47] POTENTIAL MECHANISMS OF ACTION OF INTERFERON-ALPHA IN CML
    DOWDING, C
    GORDON, M
    GUO, AP
    MAISON, D
    OSTERHOLZ, J
    SICZKOWSKI, M
    GOLDMAN, J
    LEUKEMIA & LYMPHOMA, 1993, 11 : 185 - 191
  • [48] The Results of Interferon-Alpha Treatment in Behcet Uveitis
    Eser-Ozturk, Hilal
    Sullu, Yuksel
    OCULAR IMMUNOLOGY AND INFLAMMATION, 2020, 28 (03) : 498 - 504
  • [49] Granulomatous hepatitis in a patient with chronic hepatitis C treated with interferon-alpha
    Veerabagu, MP
    Finkelstein, SD
    Rabinovitz, M
    DIGESTIVE DISEASES AND SCIENCES, 1997, 42 (07) : 1445 - 1448
  • [50] Ethnic differences in interferon-alpha allele frequencies
    Golovleva, I
    Saha, N
    Beekman, L
    HUMAN HEREDITY, 1997, 47 (04) : 185 - 188